Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

158.86
+2.621.68%
Post-market: 160.001.14+0.72%19:41 EDT
Volume:1.18M
Turnover:187.89M
Market Cap:303.10B
PE:24.02
High:159.72
Open:156.17
Low:156.10
Close:156.24
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:0.73
T/O Rate:0.06%
Dividend:4.67
Dividend Rate:2.94%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:7.30
PE(LYR):22.22

Loading ...

Novartis AG Stock (NVS) Moved Up by 3.82% on Aug 19: Key Drivers Unveiled

TradingKey
·
Aug 20

Movement Alert|Novartis AG Rises 3.11% in Regular Trading, Entresto Patent Victory Reinforces Mid-Term Revenue Outlook

Market Focus
·
Aug 20

The Key to Pharma M&A: Never Shopping Hungry - Heard on the Street

Dow Jones
·
Aug 19

Novartis’ iptacopan granted FDA orphan designation

TIPRANKS
·
Aug 19

Market Chatter: Novartis Wins UK Court Challenge to Entresto Patent

MT Newswires Live
·
Aug 13

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Novartis Might Struggle to Clear Bar in Cholesterol Drug Trial

Dow Jones
·
Aug 10

These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks

Dow Jones
·
Aug 07

Sarepta Faces Competitive Pressures Despite Pipeline Updates, RBC Says

MT Newswires Live
·
Aug 07

Correction to Novartis Wins FDA Approval for Expanded Prostate Cancer Treatment Article on July 31

Dow Jones
·
Aug 04

Novartis says FDA approves Pluvicto for PSMA+ metastatic prostate cancer

TIPRANKS
·
Aug 01

Berenberg Bank Remains a Hold on Novartis (NVS)

TIPRANKS
·
Jul 28

Berenberg Lifts Price Target on Novartis to $147 From $141, Keeps Hold Rating

MT Newswires Live
·
Jul 27

Novartis price target raised to CHF 142 from CHF 132 at Citi

TIPRANKS
·
Jul 23

Novartis (NVS) Receives a Sell from Goldman Sachs

TIPRANKS
·
Jul 22

Novartis AG Stock (NVS) Moved Up by 3.42% on Jul 21: Key Drivers Unveiled

TradingKey
·
Jul 22

Movement Alert|Novartis Rises 3.76% in Regular Trading, Q2 Earnings Significantly Beat Expectations Signaling Growth Recovery

Market Focus
·
Jul 21

Novartis Silences Generic Fears With Blowout Quarter, Packed Pipeline

Benzinga Earnings
·
Jul 21

Potential Middle East Ceasefire Lifts US Equity Futures Pre-Bell

MT Newswires Live
·
Jul 21

Novartis Returns to Growth After Key Drugs Offset Patent Expirations

Dow Jones
·
Jul 21